Heyman Richard A.
5 of 9 shown
The 5 most recent of 9 visible filings, newest first.
- Oric Pharmaceuticals, Inc. Director3,500 sharesOption exercise
- Oric Pharmaceuticals, Inc. Director$41,325Open-market sale
- Oric Pharmaceuticals, Inc. Director$45,199Open-market sale
- Oric Pharmaceuticals, Inc. Director$5,600Option exercise
- Oric Pharmaceuticals, Inc. Director3,500 sharesOption exercise